Clinical trial Recruiting at 1 site Observational Ages 18 and up

Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery

Official title: Evaluation of Appropriateness in the Use of Hemostatic Agents in Cardiovascular Surgery: A Mixed-Methods Single-Center Observational Study

Run by University of Milan · NCT07699016 · Data updated 2026-11-12

This study tests how well surgeons’ choices about topical hemostatic agents match current guidelines in cardiac and vascular surgery at one Milan hospital.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment15 (estimated)
SponsorUniversity of Milan
Academic / other
Locations1 site (Milan, MI)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedJuly 16, 2026
Study endsAugust 15, 2026
Registry record updatedJuly 13, 2026
Trial IDNCT07699016 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are attending surgeons, consulting surgeons, and surgical residents actively involved in cardiovascular operations at IRCCS Galeazzi-Sant'Ambrogio Hospital.

Probably not a fit

Non-surgical staff or surgeons not currently engaged in cardiovascular operative care may not benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

HAEMOVAX is a single-center mixed-methods observational study that combines an anonymous survey of cardiovascular surgeons with a retrospective audit of how hemostatic agents are used. It uses standardized clinical vignettes based on EACTS and ESA recommendations to measure Knowledge-Practice Alignment (KPA-Score). The study aims to understand real-world usage patterns, barriers to appropriate use, and how declared knowledge aligns with actual decision-making. Results could reveal variability in practice, inform resource allocation, and identify gaps between guidelines and routine care.

Why it matters

Potential benefit: If successful, the study could improve adherence to guidelines and reduce unnecessary use and costs of topical hemostatic agents.

How similar studies have gone: Previous research on hemostatic agent use has shown variability and gaps between guidelines and practice; this study applies a structured, real-world assessment in a single center.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Physicians with a surgical role in the Departments of Cardiac Surgery or Vascular Surgery at IRCCS Galeazzi-Sant'Ambrogio, Milan Including attending surgeons, consultant surgeons, and surgical residents
* Active participation in cardiovascular operative procedures during the study period (or within the preceding 12 months)
* Employment at the study institution at the time of survey administration Willingness to participate and complete the anonymous structured questionnaire

Exclusion Criteria:

* Non-surgical healthcare personnel (e.g., nurses, anesthesiologists, administrative staff, or allied health professionals)
* Surgeons not involved in operative cardiovascular practice during the study period
* External collaborators or visiting surgeons without regular clinical activity at the institution
* Individuals who do not provide informed consent for participation in the anonymous survey
* Questionnaires with missing or incomplete vignette responses preventing calculation of the KPA-Score

Where it's running

  • IRCCS Galeazzi Sant'Ambrogio Hospital
    Milan, Mi, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.